Figure 5.

Outcome of main immunological characteristics in mild, moderate and severe SARS‐CoV‐2 patients from diagnosis to follow‐up. (a) Lymphocyte subset counts at diagnosis and during follow‐up. (b) Plasma cytokine levels at diagnosis and at follow‐up (T‐CoV‐Spot assay). For the correlations with severity, P‐values are calculated using partial Spearman’s rank correlation coefficients, adjusted for time from symptom onset to sampling. For comparisons of plasma cytokine levels between plasma controls (n = 10) and SARS‐CoV‐2 patients classified according to severity using Dunn’s tests (post hoc for the Kruskal–Wallis test) are indicated as *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001 or ****P ≤ 0.0001. †, number of patients with available data or sample, ‡ time from symptom onset to follow‐up, in days (median [IQR]).